Quantification of EPO protein in ccRCC showed that the loss of HIF1A protein was associated with very low EPO expression, while the HIF1A presence in the tumor indicated a strong upregulation of EPO compared to HIF1A-negative tumors (p < 0.001, Figure 3B). This evidence concerns the gene HIF1A and nonpapillary renal cell carcinoma.